204 related articles for article (PubMed ID: 20631561)
1. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
Monteleone P; Milano W; Petrella C; Canestrelli B; Maj M
J Clin Psychopharmacol; 2010 Aug; 30(4):441-5. PubMed ID: 20631561
[TBL] [Abstract][Full Text] [Related]
2. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.
Monteleone P; Bifulco M; Di Filippo C; Gazzerro P; Canestrelli B; Monteleone F; Proto MC; Di Genio M; Grimaldi C; Maj M
Genes Brain Behav; 2009 Oct; 8(7):728-32. PubMed ID: 19659925
[TBL] [Abstract][Full Text] [Related]
3. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
[TBL] [Abstract][Full Text] [Related]
4. The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women.
Monteleone P; Tortorella A; Martiadis V; Di Filippo C; Canestrelli B; Maj M
Psychoneuroendocrinology; 2008 May; 33(4):546-50. PubMed ID: 18295974
[TBL] [Abstract][Full Text] [Related]
5. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
[TBL] [Abstract][Full Text] [Related]
6. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.
Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977
[TBL] [Abstract][Full Text] [Related]
7. Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
Souza RP; Tiwari AK; Chowdhury NI; Ceddia RB; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
J Psychiatr Res; 2012 Apr; 46(4):462-8. PubMed ID: 22305490
[TBL] [Abstract][Full Text] [Related]
8. Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.
Tiwari AK; Rodgers JB; Sicard M; Zai CC; Likhodi O; Freeman N; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1484-90. PubMed ID: 20732371
[TBL] [Abstract][Full Text] [Related]
9. Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.
Czerwensky F; Leucht S; Steimer W
J Clin Psychopharmacol; 2013 Feb; 33(1):74-9. PubMed ID: 23277235
[TBL] [Abstract][Full Text] [Related]
10. [Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain].
Zhang ZJ; Yao ZJ; Mou XD; Chen JF; Zhu RX; Liu W; Zhang XR; Sun J; Hou G
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2119-23. PubMed ID: 14720418
[TBL] [Abstract][Full Text] [Related]
11. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.
Tiwari AK; Zai CC; Likhodi O; Lisker A; Singh D; Souza RP; Batra P; Zaidi SH; Chen S; Liu F; Puls I; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
Neuropsychopharmacology; 2010 May; 35(6):1315-24. PubMed ID: 20107430
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels.
Chmelikova M; Pacal L; Spinarova L; Vasku A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):535-9. PubMed ID: 25270105
[TBL] [Abstract][Full Text] [Related]
13. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
14. The role of fatty acid hydrolase gene variants in inflammatory bowel disease.
Storr M; Emmerdinger D; Diegelmann J; Yüce B; Pfennig S; Ochsenkühn T; Göke B; Lohse P; Brand S
Aliment Pharmacol Ther; 2009 Mar; 29(5):542-51. PubMed ID: 19053981
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor 1 gene is associated with alcohol dependence.
Marcos M; Pastor I; de la Calle C; Barrio-Real L; Laso FJ; González-Sarmiento R
Alcohol Clin Exp Res; 2012 Feb; 36(2):267-71. PubMed ID: 22085192
[TBL] [Abstract][Full Text] [Related]
16. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
[TBL] [Abstract][Full Text] [Related]
17. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
[TBL] [Abstract][Full Text] [Related]
18. [Association of HTR2C-759C/T and -697G/C polymorphisms with antipsychotic agent-induced weight gain].
Shao P; Zhao JP; Chen JD; Wu RR; He YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):312-5. PubMed ID: 18460774
[TBL] [Abstract][Full Text] [Related]
19. Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population.
Iwasaki S; Ishiguro H; Higuchi S; Onaivi ES; Arinami T
Psychiatr Genet; 2007 Aug; 17(4):215-20. PubMed ID: 17621164
[TBL] [Abstract][Full Text] [Related]
20. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
